Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Oral Alitretinoin Treatment in Patients With Palmo-plantar Pustulosis (PPP) Inadequately Responding to Standard Topical Treatment

NCT01245140 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.

NCT NCT01245140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01245140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Oral Alitretinoin Treatment in Patients With Palmo-plantar Pustulosis (PPP) Inadequately Responding to Standard Topical Treatment
Lead sponsor
Stiefel, a GSK Company
Phase
Phase 2
Overall status
Completed
Start date
April 26, 2011
Completion date
April 16, 2014
Enrollment
33 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis